Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma
Vas Narasimhan: El médico de 42 años que pasó de tratar la malaria en Gambia a dirigir un gigante farmacéutico | Líderes
Biotech can become a powerhouse in India': Novartis' Narasimhan | Mint
CEO de Novartis ve “una mejor situación” con el Covid-19 para finales de año
Vas Narasimhan, CEO de la farmaceútica Novartis | XLSemanal
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Basel is very open to newcomers - Basel Area Business & Innovation
Performance slump takes toll on Novartis' CEO's 2022 payout
Novartis CEO Vas Narasimhan on M&A and Taking Earlier Risks on New Technology
Vas Narasimhan, chief executive officer of Novartis AG, during an... Fotografía de noticias - Getty Images
30 fotos e imágenes de Novartis Ceo Vas Narasimhan Interview - Getty Images
Vasant Narasimhan | Novartis
Novartis CEO Vas Narasimhan: Our medicines are starting to take market share and deliver on promises - YouTube
Vas Narasimhan, chief executive officer of Novartis AG, during an... Fotografía de noticias - Getty Images
Novartis prevé destinar más de 8.800 millones a la compra de otras empresas en 2019 | PlantaDoce
Novartis CEO's take-home pay jumps 59%. But there's one miss—ethics | Fierce Pharma
El CEO de Novartis advierte: una vacuna no bastará para combatir el COVID - Infobae
Vas Narasimhan | One Young World
Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug
Vas Narasimhan, CEO de la farmaceútica Novartis | XLSemanal
Vas Narasimhan Ceo Swiss Pharmaceutical Group Foto de stock de contenido editorial - Imagen de stock | Shutterstock
Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company | Ceo, Development, Company
Novartis on LinkedIn: Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global… | 281 comments
It'll take more than vaccines to fight covid-19, says Novartis CEO Vas Narasimhan | Mint
Novartis inicia una revisión exhaustiva de Beovu por sus efectos adversos
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
